Stoke Therapeutics’ (STOK) “Buy” Rating Reiterated at Chardan Capital
Chardan Capital reissued their buy rating on shares of Stoke Therapeutics (NASDAQ:STOK – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a $24 ...
Dawn20 小时
Torghar police book ANP leaders, workers over protest
An FIR was registered against ANP district president Abdul Qadir Basikhel, Kunder Hassanzai tehsil chairman Mian Nazeer and ...